This inventor holds 1 USPTO granted patent. Top assignee: Egyt Gyogyszervegyeszeti Gyar. Active years: 1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985
Title: Ildiko Fritzsche Nee Lukacs: Innovator in Antiviral Compounds
Introduction
Ildiko Fritzsche Nee Lukacs is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of medicinal chemistry, particularly in the development of antiviral compounds. Her work has implications for the treatment of viral infections, showcasing her dedication to advancing healthcare through innovation.
Latest Patents
Ildiko holds a patent for a process related to the preparation of 5-(2-bromovinyl)-uridine. This invention pertains to (E)-5-(2-bromovinyl)-uridine and its derivatives, which exhibit significant potency against Herpes simplex virus species while maintaining remarkably low acute toxicity. The patent outlines a method that involves brominating 2',3',5'-tri-O-acyl-5-ethyl-uridine and dehydrohalogenating the resulting dibromo compound, with optional deacylation to yield the final products.
Career Highlights
Ildiko is associated with Egyt Gyogyszervegyeszeti Gyar, where she has been instrumental in research and development efforts. Her innovative approach and expertise in chemistry have led to advancements in antiviral therapies, contributing to the broader scientific community's understanding of effective treatments.
Collaborations
Throughout her career, Ildiko has collaborated with esteemed colleagues, including Csilla Rethati and Istvan Koczka. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Ildiko Fritzsche Nee Lukacs exemplifies the spirit of innovation in the field of medicinal chemistry. Her contributions, particularly in antiviral research, highlight the importance of scientific inquiry and collaboration in developing effective treatments for viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile